"ValiPharma" also known as "Cronos Therapeutics" seeks to use its unique and groundbreaking epigenomic technologies to develop new classes of therapeutics and diagnostic tools, resulting in more effective detection and treatment of diseases such as cancer.

Our GeneICE compounds represent a new and innovative way of treating many diseases by acting to shut down harmful genes and therefore prevent their expression. GeneICE can be used in synergy with our HyperGenomics platform which characterizes disease state by detecting areas on the chromosome where genes are active.

At ValiPharma, we believe that our epigenomic technologies represent an important step forward in tackling disease, and will form a significant part of the future strategy for disease diagnosis and treatment.